Comatotropny hormone and insulin-like growth factors in the pathogenesis of fetal growth retardation
Abstract
Review article on the endocrine regulation of fetal growth retardation. Somatomedins and growth hormone have a similar structure of the peptide, but their influence on fetal growth varies. During pregnancy, the insulin growth factor-2 plays an important role, after the birth-insulin-like growth factor-1. Hormonal profile of the mother, her somatic disorders, the impact of external factors, production of hormones by the placenta, and gene polymorphism insulin-like growth factors influence the development of the fetus and newborn.
About the Authors
V. V. Kocherova
Chita State Medical Academy
Russian Federation
Russian Federation
V. A. Scherbak
Chita State Medical Academy
Russian Federation
Russian Federation
References
1. Андреева В.О. Роль соматотропного гормона и некоторых соматомединов в патогенезе репродуктивных расстройств при синдроме нервной анорексии // Казанский медицинский журнал. 2008. Том 89, № 2. С. 143-145.
2. Дубова Е.А., Павлова К.А., Ляпин В.М. и др. Экспрессия инсулиноподобных факторов роста в плаценте при преэклампсии // Бюллетень экспериментальной биологии и медицины. 2014. Т. 157, № 1. С. 116-121.
3. Джозеф Нью. Гастроэнтерология и питание // Проблемы и противоречия в неонатологии / под ред. Р.А. Полин. М.: Логосфера, 2014. С. 221-337.
4. Ислаимова К.Ф., Петренко Ю.В., Иванов Д.О. [и др.]. Влияние инсулиноподобного фактора роста-1 на внутриутробный и постанатальный рост у детей, родившихся с задержкой внутриутробного развития // Вестник современной клинической медицины. 2013. Т. 6, № 6. С. 36-39.
5. Колычев А.П. Инсулиноподобный фактор роста II (ИФР-2). Место среди регуляторных пептидов инсулина // Журнал эволюционной биохимии и физиологии. 2000. Т. 36, № 2. С. 69-82.
6. Пронин В.С., Колода Д.Е., Чаплыгина Е.В. Инсулиноподобные ростовые факторы в клинической практике: биологическая роль и перспективы использования // Клиницист. 2008. № 1. С. 18-26.
7. Шульга А.С., Бутенко Е.В., Александрова А.А. [и др.]. Оценка изменений уровней грелина, соматотропина, инсулиноподобного фактора роста-1, инсулина, лептина, тиреоидных гормонов в материнской и пуповинной крови при физиологической беременности с нормосомией и макросомией плода // Клиническая лабораторная диагностика. 2013. № 2. С. 16-18.
8. Abuzzahab M.J., Schneider A., Goddard A. [et al.] IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation // N. Engl. J. Med. 2003. Vol. 349, No. 23. P. 2211-2222.
9. Baker Méio M.D., Lopes Moreira M.E., Sichieri R. [et al.]. Reduction of IGF-binding protein-3 as a potential marker of intrauterine growth restriction // J. Perinat. Med. 2009. Vol. 37, No. 6. P. 689-693.
10. Bauer M.K., Harding J.E., Bassett N.S. [et al.]. Fetal growth and placental function // Mol. Cell. Endocrinol. 1998. Vol. 140, No. 1-2. P. 115-120.
11. Bowman C.J., Streck R.D., Chapin R.E. Maternal-placental insulin-like growth factor (IGF) signaling and its importance to normal embryo-fetal development // Birth. Defects. Res. B. Dev. Reprod. Toxicol. 2010. Vol. 89, No. 4. P. 339-349.
12. Herington A.C., Kuffer A.D. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity // Biochem. J. 1984. Vol. 223, No. 1. P 89-96.
13. D’Ercole J.A., Ye P. Expanding the mind: insulin-like growth factor I and brain development // Endocrinology. 2008. Vol. 149, No. 12. P. 5958-5962.
14. Guler H.P., Schmid C., Zapf J. [et al.]. Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects // Proc. Natl. Acad. Sci. USA. 1989. Vol. 86, No. 8. P. 2868-2872.
15. Hiden U., Glitzner E., Hartmann M. [et al.]. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies // J. Anat. 2009. Vol. 215, No. 1. P. 60-68.
16. Jansson N., Nilsfelt A., Gellerstedt M. [et al.]. Maternal hormones linking maternal body mass index and dietary intake to birth weight // Am. J. Clin. Nutr. 2008. Vol. 87, No. 6. P. 1743-1749.
17. Kedzia A., Tarka A., Petriczko E. [et al.]. Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women>s blood serum // Ginekol. Pol. 2013. Vol. 84, No. 7. P. 620-623.
18. King E.R., Wong K.K. Insulin-like growth factor: current concepts and new developments in cancer therapy // Recent Pat. Anticancer Drug Discov. 2012. Vol. 7, No. 1. P. 14-30.
19. Koutsaki M., Sifakis S., Zaravinos A. [et al.] Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction // Growth. Horm. IGF. Res. 2011. Vol. 21, No. 1. P. 31-36.
20. Kuemmerle J. F. Insulin-like growth factors in the gastrointestinal tract and liver // Endocrinol. Metab. Clin. North. Am. 2012. Vol. 41, No. 2. P. 409-423.
21. Lagiou P., Hsieh C.C., Samoli E. [et al.]. Associations ofplacental weight with maternal and cord blood hormones // Ann. Epidemiol. 2013. Vol. 23, No. 11. P. 669-673.
22. Lee P.D., Conover C.A., Powell D.R. Regulation and function of insulin-like growth factor-binding protein-1 // Proc. Soc. Exp. Biol. Med. 1993. Vol. 204, No. 1. P. 4-29.
23. Mahajan S.D., Singh S., Shah P. [et al.]. Effect of maternal malnutrition and anemia on the endocrine regulation of fetal growth // Endocr. Res. 2004. Vol. 30, No. 2. P. 189-203.
24. McMorris F.A., Smith T.M., DeSalvo S. [et al.]. Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development // Proc. Natl. Acad. Sci. USA. 1986. Vol. 83, No. 3. P. 822-826.
25. Nelson S.M., Freeman D.J., Sattar N. [et al.]. Role of adiponectin in matching of fetal and placental weight in mothers with type 1 diabetes // Diabetes Care. 2008. Vol. 31, No. 6. P. 1123-1125.
26. Ong K., Kratzsch J., Kiess W. [et al.]. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/ mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team Avon Longitudinal Study of Pregnancy and Childhood // J. Clin. Endocrinol. Metab. 2000. Vol. 85, No. 11. P. 4266-4269.
27. Ong K.K., Elmlinger M., Jones R. [et al.]. Growth hormone binding protein levels in children are associated with birth weight, postnatal weight gain, and insulin secretion // Metabolism. 2007. Vol. 56, No. 10. P. 1412-1417.
28. de Pablo F.L., Scott L.A., Roth J. Insulin and insulin-like growth factor I in early development: peptides, receptors and biological events // Endocr. Rev. 1990. Vol. 11, No. 4. P. 558-577.
29. Pedersen N.G., Juul A., Christiansen M. [et al.]. Maternal serum placental growth hormone, but not human placental lactogen or insulin growth factor-1, is positively associated with fetal growth in the first half of pregnancy // Ultrasound. Obstet. Gynecol. 2010. Vol. 36, No. 5. P. 534-541.
30. Ranke M.B. Sensitivity to IGF-I in short children born small for gestational age // J. Endocrinol. Invest. 2006. Vol. 29 (Suppl. 1). P. 21-26.
31. Sara V.R., Carlsson-Skwirut C., Andersson C. [et al.] Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I // Proc. Natl. Acad. Sci. USA. 1986. Vol. 83, No. 13. P. 4904-4907.
32. Setia S, Sridhar MG. Changes in GH/IGF-1 axis in intrauterine growth retardation: consequences of fetal programming? // Horm. Metab. Res. 2009. Vol. 41, No. 11. P. 791-798.
33. Sferruzzi-Perri A.N., Owens J.A., Pringle K.G. [et al.]. The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth // J. Physiol. 2011. Vol. 589. P. 7-20.
34. Tonella P. Mullis P.E. Regulation of fetal growth: consequences and impact of being born small // Best Pract. Res. Clin. Endocrinol. Metab. 2008. Vol. 22, No. 1. P. 173-190.
35. Unterman T.G. Insulin-like growth factor binding protein-1: identification, purification, and regulation in fetal and adult life // Adv. Exp. Med. Biol. 1993. Vol. 343. P. 215-226
36. Whitehead C.L., Walker S.P., Mendis S. [et al.]. Quantifying mRNA coding growth genes in the maternal circulation to detect fetal growth restriction // Am. J. Obstet. Gynecol. 2013. Vol. 209, No. 2. P. 133. e1-9.
37. Wiznitzer A., Reece E.A., Furman B. [et al.]. Fetal serum levels of insulin, growth hormone and insulin-like growth factor-I in concordant and discordant twin gestations // J. Matern. Fetal. Med. 2001. Vol. 10, No. 4. P. 236-240.
38. Zhou J., Shi Y., Dong M. Influence of growth hormone-insulinlike growth factor I axis on normal pregnancy // Chin. Med. J. (Engl). 2001. Vol. 114, No. 9. P. 988-990.
Review
For citations:
Kocherova V.V., Scherbak V.A. Comatotropny hormone and insulin-like growth factors in the pathogenesis of fetal growth retardation. Pacific Medical Journal. 2016;(1):5-8. (In Russ.)
Views:
419
Email this article 